BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23530389)

  • 21. Infant pertussis epidemiology and implications for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination: King County, Washington, 2002 through 2007.
    Hanson MP; Kwan-Gett TS; Baer A; Rietberg K; Ohrt M; Duchin JS
    Arch Pediatr Adolesc Med; 2011 Jul; 165(7):647-52. PubMed ID: 21727277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal pertussis immunization: can it help infants?
    Jiménez-Truque N; Edwards KM
    JAMA; 2014 May; 311(17):1736-7. PubMed ID: 24794364
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR
    Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunogenicity and reactogenicity of acellular pertussis vaccines intended for adolescent and adults].
    Zawadka M; Lutyńska A
    Przegl Epidemiol; 2012; 66(1):99-105. PubMed ID: 22708307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From the Centers for Disease Control and Prevention. Pertussis--United States, 1997-2000.
    JAMA; 2002 Feb; 287(8):977-9. PubMed ID: 11871441
    [No Abstract]   [Full Text] [Related]  

  • 27. [Time for booster doses against whooping cough for 10-year-old children].
    Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
    Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy trial of acellular pertussis vaccines; trial I.
    Olin P
    Dev Biol Stand; 1997; 89():52-4. PubMed ID: 9333569
    [No Abstract]   [Full Text] [Related]  

  • 29. Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine.
    Weston W; Messier M; Friedland LR; Wu X; Howe B
    Vaccine; 2011 Nov; 29(47):8483-6. PubMed ID: 21945698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Japanese experience with 60 million doses of acellular pertussis vaccines.
    Sato H
    Dev Biol Stand; 1997; 89():327-9. PubMed ID: 9272367
    [No Abstract]   [Full Text] [Related]  

  • 31. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jan; 60(1):13-5. PubMed ID: 21228763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The present and future control of pertussis.
    Cherry JD
    Clin Infect Dis; 2010 Sep; 51(6):663-7. PubMed ID: 20704492
    [No Abstract]   [Full Text] [Related]  

  • 34. Bordetella pertussis booster vaccination for health care personnel immediately following a pertussis outbreak in a hospital?
    Birkebaek NH
    Clin Infect Dis; 2009 Aug; 49(4):588-90. PubMed ID: 19589080
    [No Abstract]   [Full Text] [Related]  

  • 35. How can we best prevent pertussis in infants?
    Libster R; Edwards KM
    Clin Infect Dis; 2012 Jan; 54(1):85-7. PubMed ID: 22075789
    [No Abstract]   [Full Text] [Related]  

  • 36. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.
    Gidengil CA; Sandora TJ; Lee GM
    Expert Rev Vaccines; 2008 Jul; 7(5):621-34. PubMed ID: 18564017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stop pertussis too.
    McPartlan D
    Nursing; 2007 Apr; 37(4):10. PubMed ID: 17413329
    [No Abstract]   [Full Text] [Related]  

  • 38. Tetanus-diptheria-acellular pertussis (Tdap): tap the resources of the emergency department to fight pertussis.
    Adalja AA
    J Emerg Med; 2011 May; 40(5):548-9. PubMed ID: 19406600
    [No Abstract]   [Full Text] [Related]  

  • 39. Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults.
    Mertsola J; Van Der Meeren O; He Q; Linko-Parvinen A; Ramakrishnan G; Mannermaa L; Soila M; Pulkkinen M; Jacquet JM
    Clin Infect Dis; 2010 Sep; 51(6):656-62. PubMed ID: 20704493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of cocooning against pertussis in a high-risk population.
    Healy CM; Rench MA; Baker CJ
    Clin Infect Dis; 2011 Jan; 52(2):157-62. PubMed ID: 21288837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.